4//SEC Filing
Shabbir Anik 4
Accession 0001209191-22-006121
CIK 0001382101other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 8:32 PM ET
Size
9.2 KB
Accession
0001209191-22-006121
Insider Transaction Report
Form 4
Shabbir Anik
Chief Technical Ops. Officer
Transactions
- Exercise/Conversion
Common Stock
2022-01-29+4,500→ 24,053 total - Tax Payment
Common Stock
2022-01-29$10.39/sh−1,844$19,159→ 22,209 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2021-01-29−4,500→ 9,000 totalExp: 2025-01-29→ Common Stock (4,500 underlying)
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001751728
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 8:32 PM ET
- Size
- 9.2 KB